ONCAlert | Upfront Therapy for mRCC

Lung Cancer 1 MORE >>

During the 20th Annual International Lung Cancer Congress, Targeted Oncology spoke with another Lung-MAP investigator, Fred R. Hirsch, MD, PhD, about the status and importance of the trial and new recommendations for molecular testing and liquid biopsies working their way into practice in the lung cancer field.

Latest JournalAll Journals >>

Copyright © TargetedOnc 2019 Intellisphere, LLC. All Rights Reserved.